Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures

Recent studies indicate that selective noradrenergic (atomoxetine) and serotonergic (citalopram) reuptake inhibitors may improve response inhibition in selected patients with Parkinson's disease, restoring behavioral performance and brain activity. We reassessed the behavioral efficacy of these...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Brain Mapp
Main Authors: Ye, Zheng, Rae, Charlotte L., Nombela, Cristina, Ham, Timothy, Rittman, Timothy, Jones, Peter Simon, Rodríguez, Patricia Vázquez, Coyle‐Gilchrist, Ian, Regenthal, Ralf, Altena, Ellemarije, Housden, Charlotte R., Maxwell, Helen, Sahakian, Barbara J., Barker, Roger A., Robbins, Trevor W., Rowe, James B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819701/
https://ncbi.nlm.nih.gov/pubmed/26757216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.23087
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados